SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-15-003151
Filing Date
2015-04-30
Accepted
2015-04-30 12:37:41
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT TO AMENDMENT NO. 4 ff12015a4_biondvax.htm F-1/A 63103
2 OPINION ff12015a4ex5i_biondvax.htm EX-5.1 14473
3 OPINION ff12015a4ex5ii_biondvax.htm EX-5.2 13153
4 GRAPHIC image_001.jpg GRAPHIC 2144
5 GRAPHIC image_002.jpg GRAPHIC 2144
  Complete submission text file 0001213900-15-003151.txt   97877
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: F-1/A | Act: 33 | File No.: 333-201283 | Film No.: 15816615
SIC: 2836 Biological Products, (No Diagnostic Substances)